Fredun Pharmaceuticals shareholders and shareholding pattern
NSE: FREDUNBSE: 539730Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,368.40down ₹22.60 (1.62%)BSE ₹1,368.10
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,391.00.
52-week range of BSE trades to 23 Oct 2026
₹454.05Low, 12 Jan 2026₹1,666.35High, 8 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,313 Cr1,474th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 8.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.80
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 52,74940.2% delivered
Who owns Fredun Pharmaceuticals, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters43.62%
- Foreign institutions0.69%
- Indian institutions3.44%
- Individuals and others52.25%
Shareholding pattern, per cent, from Dec 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 23 Jan | Mar 2017Filed 17 Apr | Jun 2017Filed 21 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 20 Apr | Mar 2018Filed 24 Apr | Jun 2018Filed 16 Jul | Sep 2018Filed 12 Oct | Dec 2018Filed 9 Jan | Mar 2019Filed 10 Apr | Jun 2019Filed 20 Jul | Sep 2019Filed 10 Oct | Dec 2019Filed 14 Jan | Mar 2020Filed 11 May | Jun 2020Filed 10 Jul | Sep 2020Filed 12 Oct | Dec 2020Filed 11 Jan | Mar 2021Filed 3 May | Jun 2021Filed 12 Jul | Sep 2021Filed 13 Oct | Dec 2021Filed 11 Jan | Mar 2022Filed 19 Apr | Jun 2022Filed 19 Jul | Dec 2022Filed 17 Jan | Mar 2023Filed 15 Apr | Jun 2023Filed 31 Jul | Sep 2023Filed 19 Oct | Dec 2023Filed 20 Jan | Mar 2024Filed 18 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 19 Oct | Dec 2024Filed 18 Jan | Mar 2025Filed 21 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 21 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 13 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.44% | 74.44% | 74.44% | 59.86% | 59.86% | 54.04% | 54.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 51.27% | 51.27% | 51.04% | 50.34% | 50.15% | 49.62% | 49.31% | 49.16% | 49.17% | 49.17% | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% | 43.06% | 44.17% | 44.57% | 43.62% | |
| Indian promoters | 74.44% | 74.44% | 74.44% | 59.86% | 59.86% | 54.04% | 54.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 52.04% | 51.27% | 51.27% | 51.04% | 50.34% | 50.15% | 49.62% | 49.31% | 49.16% | 49.17% | 49.17% | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% | 43.06% | 44.17% | 44.57% | 43.62% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 25.56% | 25.56% | 25.56% | 40.14% | 40.14% | 45.96% | 45.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 47.96% | 48.73% | 48.73% | 48.96% | 49.66% | 49.85% | 50.38% | 50.69% | 50.84% | 50.83% | 50.83% | 51.07% | 51.07% | 51.07% | 51.07% | 51.07% | 56.94% | 55.83% | 55.43% | 56.38% |
| Promoter shares pledgedShare of the promoters' own shares | 0.00% | 0.00% | 14.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.85% | 3.85% | 5.54% | 5.54% | 5.54% | 5.54% | 5.54% | 5.54% | 5.54% | 5.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Shares in issue | 23,52,400 | 23,52,400 | 23,52,400 | 29,25,135 | 29,25,135 | 34,25,134 | 34,25,134 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 39,89,634 | 44,32,643 | 44,32,643 | 44,52,779 | 45,14,772 | 45,32,272 | 45,80,122 | 46,84,162 | 46,99,162 | 46,99,162 | 46,99,162 | 47,21,662 | 47,21,662 | 47,21,662 | 47,21,662 | 47,21,662 | 53,66,022 | 54,72,690 | 55,12,690 | 1,68,99,669what Shares in issue, Sep 2026, includes. Bonus issue on 16 Jul 2026: 2 new shares for every 1 held. Earlier filings count the shares before it. |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | – | – | – | 5,73,648 | 23,21,158 | 17,52,023 | 28,24,857 | 33,89,357 | 33,89,357 | 33,88,444 | 16,37,234 | 3,25,000 | 3,26,800 | 3,26,800 | 4,99,600 | 3,25,000 | 3,25,000 | 3,25,000 | 3,25,000 | 18,01,010 | 25,92,352 | 25,92,352 | 26,12,488 | 20,33,349 | 18,28,166 | 2,11,703 | 3,66,025 | 3,81,025 | 3,33,175 | 3,15,675 | 2,71,275 | 2,71,275 | 59,640 | 59,640 | 19,072 | 22,65,218 | 23,71,895 | 23,96,760 | 56,19,799 |
| Promoters' shares locked in | – | – | – | 0 | 17,47,510 | 17,51,110 | 18,51,110 | 20,76,110 | 20,76,110 | 20,76,110 | 3,25,000 | 3,25,000 | 3,25,000 | 3,25,000 | 4,99,600 | 3,25,000 | 3,25,000 | 3,25,000 | 3,25,000 | 18,01,010 | 21,12,645 | 21,12,645 | 21,12,645 | 16,97,445 | 16,97,445 | 1,96,635 | 2,33,775 | 2,33,775 | 2,33,775 | 2,33,775 | 2,33,775 | 2,33,775 | 37,140 | 37,140 | 19,072 | 15,90,570 | 16,97,238 | 17,37,238 | 52,11,714 |
Filings before Dec 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. Pledged is the share of the promoters' own shares given to lenders as security. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Fredun Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is DAULAT NARIMAN MEDHORA, 38.53%.Promoter buying and selling
| Holder | |||
|---|---|---|---|
| DAULAT NARIMAN MEDHORAIndividuals and Hindu undivided families | 38.53% | 65,11,239 | 66.85% |
| FREDUN NARIMAN MEDHORAIndividuals and Hindu undivided families | 5.08% | 8,59,020 | 100.00% |
| NARIMAN BAMANSHA MEDHORAIndividuals and Hindu undivided families | 0.01% | 900 | 0.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Fredun Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 23 Jan | Mar 2017Filed 17 Apr | Jun 2017Filed 21 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 20 Apr | Mar 2018Filed 24 Apr | Jun 2018Filed 16 Jul | Sep 2018Filed 12 Oct | Dec 2018Filed 9 Jan | Mar 2019Filed 10 Apr | Jun 2019Filed 20 Jul | Sep 2019Filed 10 Oct | Dec 2019Filed 14 Jan | Mar 2020Filed 11 May | Jun 2020Filed 10 Jul | Sep 2020Filed 12 Oct | Dec 2020Filed 11 Jan | Mar 2021Filed 3 May | Jun 2021Filed 12 Jul | Sep 2021Filed 13 Oct | Dec 2021Filed 11 Jan | Mar 2022Filed 19 Apr | Jun 2022Filed 19 Jul | Dec 2022Filed 17 Jan | Mar 2023Filed 15 Apr | Jun 2023Filed 31 Jul | Sep 2023Filed 19 Oct | Dec 2023Filed 20 Jan | Mar 2024Filed 18 Apr | Jun 2024Filed 19 Jul | Sep 2024Filed 19 Oct | Dec 2024Filed 18 Jan | Mar 2025Filed 21 Apr | Jun 2025Filed 19 Jul | Sep 2025Filed 18 Oct | Dec 2025Filed 21 Jan | Mar 2026Filed 17 Apr | Jun 2026Filed 13 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NIKHIL KISHORCHANDRA VORAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.93% | 6.90% | 6.82% | 6.58% | 6.50% | 6.50% | 6.41% | 6.38% | 6.38% | 6.38% | 6.38% | 6.38% | 5.61% | 5.50% | – | 5.28% |
| ALCHEMY LONG TERM VENTURES FUND, SERIES 2Alternative investment funds | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.42% |
| AJAY KUMAR AGGARWALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.42% |
| BANK OF INDIABanks | 3.19% | 3.19% | 3.19% | 2.56% | 2.56% | 2.19% | 2.19% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.88% | 1.69% | 1.69% | 1.68% | 1.66% | 1.65% | 1.64% | 1.60% | 1.60% | 1.60% | 1.60% | 1.59% | 1.59% | 1.59% | 1.59% | 1.59% | 1.40% | 1.37% | 1.36% | 1.33% |
| ARUN KUMAR MUKHERJEEResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% | 1.01% | 1.00% | 1.12% | 1.16% | 1.21% | 1.45% | 1.44% | 1.51% | 1.70% | 1.43% | 1.03% | 1.03% | 1.02% | 1.06% | – | 1.05% | – | 1.31% |
| ALCHEMY CAPITAL MANAGEMENT PVT LTDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% |
| CAPRI GLOBAL VENTURES PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.01% |
| NAV CAPITAL VCC - NAV CAPITAL EMERGING STAR FUNDForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | 1.02% | 1.02% | – |
| CAPRI GLOBAL HOLDINGS PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.49% | 1.46% | – | – |
| HARSHA VENKATESHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | 1.06% | 1.06% | – | – | – | – |
| NIKHIL VORAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | 6.81% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 5.85% | 7.67% | 7.67% | 7.64% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| RUDRA MURTHY B V .Resident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | – | 1.04% | 1.04% | 1.04% | 1.04% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| S S SEEMAResident individuals, over ₹2 lakh at face value | – | – | – | 2.05% | 2.05% | 1.75% | 1.75% | 1.50% | 1.50% | 1.50% | 1.50% | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% | 1.38% | 1.05% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| VACHANA INVESTMENTS PRIVATE LIMITEDResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| INDIA MAX INVESTMENT FUND LIMITEDInstitutions Foreign Portfolio Investor | – | – | – | 2.29% | 2.29% | 1.96% | 1.96% | 1.68% | 1.68% | 1.68% | 1.68% | 1.25% | 1.25% | 1.23% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| URMILADEVI TAPARIAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| K R KARTHIKEYANResident individuals, over ₹2 lakh at face value | – | – | – | 1.37% | 1.37% | 1.17% | 1.17% | 1.00% | 1.00% | 1.00% | 1.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| GOTHAMCHAND AResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | 1.17% | 1.00% | 1.00% | 1.00% | 1.00% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SUDHABEN MANHARLAL DOSHIResident individuals, over ₹2 lakh at face value | 2.64% | 2.64% | 2.64% | 2.12% | 2.12% | 1.81% | 1.53% | 1.16% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AUTOLEC INTERNATIONAL PRIVATE LIMITEDOther non-institutions | – | – | – | – | – | – | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| MR. NIKHIL VORAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | 6.81% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| A GOTHAMCHANDResident individuals, over ₹2 lakh at face value | – | – | – | 1.37% | 1.37% | 1.17% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| AUTOLEC INTERNATIONAL P LTDOther non-institutions | – | – | – | 1.20% | 1.20% | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| F.L.DADABHOYResident individuals, over ₹2 lakh at face value | – | – | – | 1.03% | 1.03% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.